Docplix Secures Rs 1.2 Crore in Bridge Round

Preeti Bali / 10:02 am / June 7, 2024

Docplix, a healthtech startup, has successfully secured Rs 1.2 crore in a bridge funding round led by Inflection Point Ventures (IPV). This latest investment follows a pre-Series A round of Rs 5 crore led by Eris Lifesciences in March 2024, along with an earlier seed funding round of Rs 1.2 crore in February 2022.

Fueling Innovation: Product Development and AI Integration

Docplix intends to leverage the new influx of capital to fuel product development and integrate advanced AI functionalities. This strategic investment will focus on enhancing their Electronic Health Record (EHR) system, allowing for more secure and interoperable management of patient data. Additionally, Docplix plans to incorporate cutting-edge AI capabilities to improve decision support for healthcare professionals, ultimately leading to better patient care.

A Commitment to Expanding Market Reach

A significant portion of the funding will be dedicated to market expansion initiatives. Docplix aims to extend its reach to a wider audience, particularly in underserved areas. The company plans to achieve this by implementing programs and establishing remote clinics in tier-II and tier-III cities.

Streamlining Healthcare with Technology

Founded by Varun Garg and Aayush Garg, Docplix is dedicated to streamlining healthcare delivery through innovative technology. Their EHR system adheres to Ayushman Bharat Digital Mission (ABDM) compliance, ensuring the secure management of patient data. Furthermore, Docplix’s integrated Decision Support System (DSS) empowers healthcare professionals by leveraging data analytics to make informed decisions. The platform also boasts user-friendly visualization tools, making patient data easier to understand and interpret, ultimately enhancing both patient care and clinic efficiency.

Serving Over 2,000 Doctors and Beyond

Docplix has already established a strong presence in the healthcare sector, currently serving over 2,000 doctors. With this new funding round, the company is poised to significantly expand its reach and revolutionize healthcare delivery, particularly in underserved communities.


More Stories